| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 485 | 4.137 | 2.193 | 3.661 | 19.128 | 34.869 | 137.606 |
| Total Income - EUR | - | - | - | 485 | 4.137 | 2.193 | 3.674 | 19.128 | 34.869 | 137.606 |
| Total Expenses - EUR | - | - | - | 60 | 111 | 123 | 96 | 925 | 6.574 | 86.748 |
| Gross Profit/Loss - EUR | - | - | - | 425 | 4.026 | 2.070 | 3.578 | 18.202 | 28.295 | 50.859 |
| Net Profit/Loss - EUR | - | - | - | 410 | 3.902 | 2.007 | 3.468 | 17.629 | 23.701 | 42.512 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
Check the financial reports for the company - Mem Healthcare & Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 6.044 | 84.373 | 106.020 |
| Current Assets | - | - | - | 475 | 4.404 | 2.057 | 5.545 | 11.846 | 11.895 | 52.666 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 763 | 108 |
| Receivables | - | - | - | 0 | 87 | 3 | 0 | 11 | 4.823 | 28.619 |
| Cash | - | - | - | 475 | 4.317 | 2.054 | 5.545 | 11.835 | 6.310 | 23.939 |
| Shareholders Funds | - | - | - | 453 | 4.347 | 2.057 | 5.479 | 17.677 | 41.325 | 83.646 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 80 |
| Debts | - | - | - | 21 | 58 | 0 | 66 | 212 | 104.437 | 99.912 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 28.103 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mem Healthcare & Research S.r.l.